Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

5.09
Delayed Data
As of Feb 05
 -0.08 / -1.55%
Today’s Change
4.50
Today|||52-Week Range
17.55
-19.97%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close5.17
Today’s open5.36
Day’s range5.03 - 5.36
Volume10,649
Average volume (3 months)69,232
Market cap$339.9M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+4.67%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
CFMSConforMIS Inc-0.75-7.22%
VASCVascular Solutions I...-0.98-3.76%
RTIXRTI Surgical Inc-0.21-6.50%
AAVLAvalanche Biotechnol...-0.27-5.73%
Data as of 02/05/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Partner Offers